Cancer drugs profiling

Anti-cancer drugs profiling

Fluofarma developed DCffer® method, a powerful approach for anti-cancer drugs profiling. This innovative profiling method compares your anti-cancer drugs to a proprietary functional signature database of reference anti-cancer compounds.

The DCffer® method, for anti-cancer drugs profiling is based on 3 major steps:

• Testing of your anti-cancer drugs by detecting 4 key parameters: DNA strand breaks, proliferation inhibition, apoptosis and cytolysis at different time points.
• Determination of a unique signature integrating potency and efficacy of your anti-cancer drugs.
• Profiling of your anti-cancer drugs comparing its signature with a database of reference anti-cancer compounds.

For more information on cancer drugs profiling

If you need to have further details on our cancer drugs profiling, do not hesitate to contact us.